Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Effects of Telomerase and Telomere Length on Epidermal Stem Cell Behavior
Ignacio Flores,
María L. Cayuela,
María A. Blasco*
Abstract:
A key process in organ homeostasis is the mobilization of stemcells out of their niches. We show through analysis of mousemodels that telomere length, as well as the catalytic componentof telomerase, Tert, are critical determinants in the mobilizationof epidermal stem cells. Telomere shortening inhibited mobilizationof stem cells out of their niche, impaired hair growth, andresulted in suppression of stem cell proliferative capacityin vitro. In contrast, Tert overexpression in the absence ofchanges in telomere length promoted stem cell mobilization,hair growth, and stem cell proliferation in vitro. The effectsof telomeres and telomerase on stem cell biology anticipatetheir role in cancer and aging.
Telomeres and Telomerase Group, Molecular Oncology Program, Spanish National Cancer Centre (CNIO), Melchor Fernández Almagro 3, Madrid E-28029, Spain.
* To whom correspondence should be addressed. E-mail: mblasco{at}cnio.es
The editors suggest the following Related Resources on Science sites:
Dual role for mammalian DNA polymerase {zeta} in maintaining genome stability and proliferative responses.
S. S. Lange, E. Bedford, S. Reh, J. P. Wittschieben, S. Carbajal, D. F. Kusewitt, J. DiGiovanni, and R. D. Wood (2013)
PNAS
110, E687-E696
|Abstract »|Full Text »|PDF »
HnRNP A1 phosphorylated by VRK1 stimulates telomerase and its binding to telomeric DNA sequence.
Y. H. Choi, J.-K. Lim, M.-W. Jeong, and K.-T. Kim (2012)
Nucleic Acids Res.
40, 8499-8518
|Abstract »|Full Text »|PDF »
Maintenance of tumor initiating cells of defined genetic composition by nucleostemin.
N. Okamoto, M. Yasukawa, C. Nguyen, V. Kasim, Y. Maida, R. Possemato, T. Shibata, K. L. Ligon, K. Fukami, W. C. Hahn, et al. (2011)
PNAS
108, 20388-20393
|Abstract »|Full Text »|PDF »
Separation of telomerase functions by reverse genetics.
S. Mukherjee, E. J. Firpo, Y. Wang, and J. M. Roberts (2011)
PNAS
108, E1363-E1371
|Abstract »|Full Text »|PDF »
Kruppel-Like Factor 9 Loss-of-Expression in Human Endometrial Carcinoma Links Altered Expression of Growth-Regulatory Genes with Aberrant Proliferative Response to Estrogen.
C. D. Simmons, J. M. P. Pabona, M. E. Heard, T. M. Friedman, M. T. Spataro, A. L. Godley, F. A. Simmen, A. F. Burnett, and R. C. M. Simmen (2011)
Biol Reprod
85, 378-385
|Abstract »|Full Text »|PDF »
Insulin-Like Growth Factor-1 Receptor Identifies a Pool of Human Cardiac Stem Cells With Superior Therapeutic Potential for Myocardial Regeneration.
D. D'Amario, M. C. Cabral-Da-Silva, H. Zheng, C. Fiorini, P. Goichberg, E. Steadman, J. Ferreira-Martins, F. Sanada, M. Piccoli, D. Cappetta, et al. (2011)
Circ. Res.
108, 1467-1481
|Abstract »|Full Text »|PDF »
Partial pneumonectomy of telomerase null mice carrying shortened telomeres initiates cell growth arrest resulting in a limited compensatory growth response.
S.-R. Jackson, J. Lee, R. Reddy, G. N. Williams, A. Kikuchi, Y. Freiberg, D. Warburton, and B. Driscoll (2011)
Am J Physiol Lung Cell Mol Physiol
300, L898-L909
|Abstract »|Full Text »|PDF »
Biologic function and clinical potential of telomerase and associated proteins in cardiovascular tissue repair and regeneration.
R. Madonna, R. De Caterina, J. T. Willerson, and Y.-J. Geng (2011)
Eur. Heart J.
32, 1190-1196
|Abstract »|Full Text »|PDF »
Telomerase reverse transcriptase protects ATM-deficient hematopoietic stem cells from ROS-induced apoptosis through a telomere-independent mechanism.
E. Nitta, M. Yamashita, K. Hosokawa, M. Xian, K. Takubo, F. Arai, S. Nakada, and T. Suda (2011)
Blood
117, 4169-4180
|Abstract »|Full Text »|PDF »
Telomerase Activation in Atherosclerosis and Induction of Telomerase Reverse Transcriptase Expression by Inflammatory Stimuli in Macrophages.
F. Gizard, E. B. Heywood, H. M. Findeisen, Y. Zhao, K. L. Jones, C. Cudejko, G. R. Post, B. Staels, and D. Bruemmer (2011)
Arterioscler Thromb Vasc Biol
31, 245-252
|Abstract »|Full Text »|PDF »
R. K. Montgomery, D. L. Carlone, C. A. Richmond, L. Farilla, M. E. G. Kranendonk, D. E. Henderson, N. Y. Baffour-Awuah, D. M. Ambruzs, L. K. Fogli, S. Algra, et al. (2011)
PNAS
108, 179-184
|Abstract »|Full Text »|PDF »
SIRT1 contributes to telomere maintenance and augments global homologous recombination.
J. A. Palacios, D. Herranz, M. L. De Bonis, S. Velasco, M. Serrano, and M. A. Blasco (2010)
J. Cell Biol.
191, 1299-1313
|Abstract »|Full Text »|PDF »
The Telomerase Inhibitor Imetelstat Depletes Cancer Stem Cells in Breast and Pancreatic Cancer Cell Lines.
I. Joseph, R. Tressler, E. Bassett, C. Harley, C. M. Buseman, P. Pattamatta, W. E. Wright, J. W. Shay, and N. F. Go (2010)
Cancer Res.
70, 9494-9504
|Abstract »|Full Text »|PDF »
ATR suppresses telomere fragility and recombination but is dispensable for elongation of short telomeres by telomerase.
C. J. McNees, A. M. Tejera, P. Martinez, M. Murga, F. Mulero, O. Fernandez-Capetillo, and M. A. Blasco (2010)
J. Cell Biol.
188, 639-652
|Abstract »|Full Text »|PDF »
Reprogramming Murine Telomerase Rapidly Inhibits the Growth of Mouse Cancer Cells In vitro and In vivo.
T. Xu, Y. Xu, C.-P. Liao, R. Lau, and A. Goldkorn (2010)
Mol. Cancer Ther.
9, 438-449
|Abstract »|Full Text »|PDF »
Comparing effects of mTR and mTERT deletion on gene expression and DNA damage response: a critical examination of telomere length maintenance-independent roles of telomerase.
S. L. Vidal-Cardenas and C. W. Greider (2010)
Nucleic Acids Res.
38, 60-71
|Abstract »|Full Text »|PDF »
Correlation of Telomere Length and Telomerase Activity with Occult Ovarian Insufficiency.
S. Butts, H. Riethman, S. Ratcliffe, A. Shaunik, C. Coutifaris, and K. Barnhart (2009)
J. Clin. Endocrinol. Metab.
94, 4835-4843
|Abstract »|Full Text »|PDF »
Telomere Shortening in Neural Stem Cells Disrupts Neuronal Differentiation and Neuritogenesis.
S. R. Ferron, M. A. Marques-Torrejon, H. Mira, I. Flores, K. Taylor, M. A. Blasco, and I. Farinas (2009)
J. Neurosci.
29, 14394-14407
|Abstract »|Full Text »|PDF »
Increased telomere fragility and fusions resulting from TRF1 deficiency lead to degenerative pathologies and increased cancer in mice.
P. Martinez, M. Thanasoula, P. Munoz, C. Liao, A. Tejera, C. McNees, J. M. Flores, O. Fernandez-Capetillo, M. Tarsounas, and M. A. Blasco (2009)
Genes & Dev.
23, 2060-2075
|Abstract »|Full Text »|PDF »
Activation of Telomerase by Human Cytomegalovirus.
K. Straat, C. Liu, A. Rahbar, Q. Zhu, L. Liu, N. Wolmer-Solberg, F. Lou, Z. Liu, J. Shen, J. Jia, et al. (2009)
J Natl Cancer Inst
101, 488-497
|Abstract »|Full Text »|PDF »
TRF1 Controls Telomere Length and Mitotic Fidelity in Epithelial Homeostasis.
P. Munoz, R. Blanco, G. de Carcer, S. Schoeftner, R. Benetti, J. M. Flores, M. Malumbres, and M. A. Blasco (2009)
Mol. Cell. Biol.
29, 1608-1625
|Abstract »|Full Text »|PDF »
Review Paper: Origin and Molecular Pathology of Adrenocortical Neoplasms.
M. Bielinska, H. Parviainen, S. Kiiveri, M. Heikinheimo, and D. B. Wilson (2009)
Veterinary Pathology
46, 194-210
|Abstract »|Full Text »|PDF »
Genetic dissection of the mechanisms underlying telomere-associated diseases: impact of the TRF2 telomeric protein on mouse epidermal stem cells.
Telomere biology in cardiovascular disease: the TERC-/- mouse as a model for heart failure and ageing.
L. S.M. Wong, H. Oeseburg, R. A. de Boer, W. H. van Gilst, D. J. van Veldhuisen, and P. van der Harst (2009)
Cardiovasc Res
81, 244-252
|Abstract »|Full Text »|PDF »
Lung alveolar integrity is compromised by telomere shortening in telomerase-null mice.
J. Lee, R. Reddy, L. Barsky, J. Scholes, H. Chen, W. Shi, and B. Driscoll (2009)
Am J Physiol Lung Cell Mol Physiol
296, L57-L70
|Abstract »|Full Text »|PDF »
Generation of mTert-GFP mice as a model to identify and study tissue progenitor cells.
D. T. Breault, I. M. Min, D. L. Carlone, L. G. Farilla, D. M. Ambruzs, D. E. Henderson, S. Algra, R. K. Montgomery, A. J. Wagers, and N. Hole (2008)
PNAS
105, 10420-10425
|Abstract »|Full Text »|PDF »
Therapeutic Implications of Leukemic Stem Cell Pathways.
S. Chumsri, W. Matsui, and A. M Burger (2008)
Am. Assoc. Cancer Res. Educ. Book
2008, 397-406
|Abstract »|Full Text »|PDF »
Nuclear envelope defects cause stem cell dysfunction in premature-aging mice.
J. Espada, I. Varela, I. Flores, A. P. Ugalde, J. Cadinanos, A. M. Pendas, C. L. Stewart, K. Tryggvason, M. A. Blasco, J. M.P. Freije, et al. (2008)
J. Cell Biol.
181, 27-35
|Abstract »|Full Text »|PDF »
The longest telomeres: a general signature of adult stem cell compartments.
I. Flores, A. Canela, E. Vera, A. Tejera, G. Cotsarelis, and M. A. Blasco (2008)
Genes & Dev.
22, 654-667
|Abstract »|Full Text »|PDF »
Telomerase reverse transcriptase expression elevated by avian leukosis virus integration in B cell lymphomas.
F. Yang, R. R. Xian, Y. Li, T. S. Polony, and K. L. Beemon (2007)
PNAS
104, 18952-18957
|Abstract »|Full Text »|PDF »
Therapeutic Implications of Leukemic Stem Cell Pathways.
S. Chumsri, W. Matsui, and A. M. Burger (2007)
Clin. Cancer Res.
13, 6549-6554
|Abstract »|Full Text »|PDF »
Multipotent cells can be generated in vitro from several adult human organs (heart, liver, and bone marrow).
A. P. Beltrami, D. Cesselli, N. Bergamin, P. Marcon, S. Rigo, E. Puppato, F. D'Aurizio, R. Verardo, S. Piazza, A. Pignatelli, et al. (2007)
Blood
110, 3438-3446
|Abstract »|Full Text »|PDF »
Telomerase reverses epidermal hair follicle stem cell defects and loss of long-term survival associated with critically short telomeres.
I. Siegl-Cachedenier, I. Flores, P. Klatt, and M. A. Blasco (2007)
J. Cell Biol.
179, 277-290
|Abstract »|Full Text »|PDF »
Visualizing the dynamics of p21Waf1/Cip1 cyclin-dependent kinase inhibitor expression in living animals.
N. Ohtani, Y. Imamura, K. Yamakoshi, F. Hirota, R. Nakayama, Y. Kubo, N. Ishimaru, A. Takahashi, A. Hirao, T. Shimizu, et al. (2007)
PNAS
104, 15034-15039
|Abstract »|Full Text »|PDF »
Regulation and Effects of Modulation of Telomerase Reverse Transcriptase Expression in Primordial Germ Cells During Development.
M. Coussens, Y. Yamazaki, S. Moisyadi, R. Suganuma, R. Yanagimachi, and R. Allsopp (2006)
Biol Reprod
75, 785-791
|Abstract »|Full Text »|PDF »
Transforming Growth Factor beta Suppresses Human Telomerase Reverse Transcriptase (hTERT) by Smad3 Interactions with c-Myc and the hTERT Gene.
H. Li, D. Xu, J. Li, M. C. Berndt, and J.-P. Liu (2006)
J. Biol. Chem.
281, 25588-25600
|Abstract »|Full Text »|PDF »
Genetic Analysis of Myc and Telomerase Interactions In Vivo.
I. Flores, G. Evan, and M. A. Blasco (2006)
Mol. Cell. Biol.
26, 6130-6138
|Abstract »|Full Text »|PDF »
Assembly of Mutant-Template Telomerase RNA into Catalytically Active Telomerase Ribonucleoprotein That Can Act on Telomeres Is Required for Apoptosis and Cell Cycle Arrest in Human Cancer Cells.